Welcome to LookChem.com Sign In|Join Free
  • or
Tai'an Jia Ye Biological Technology Co.,LtdNew Type Fat Loss Durgs 282526-98-1//www.lookchem.com/300w//2010/0620/282526-98-1.jpg
  • Mr.Jack Smith
  • Ms.Amanda
  • Mr.Alex
  • Ms.Annie

Communicate with Supplier:

Mr. Alex
Mr. Alex: What can I do for you?

New Type Fat Loss Durgs 282526-98-1 CAS NO.282526-98-1

Min.Order Quantity:
10 Gram
Payment Terms:
L/C,T/T,Western Union,MoneyGram,Other

Add to Inquiry Cart

Product Details


  • Cetilistat
  • New Type Fat Loss Durgs
  • 282526-98-1

Quick Details

  • ProName: New Type Fat Loss Durgs 282526-98-1
  • CasNo: 282526-98-1
  • Appearance: white powder
  • Application: Fat Loss Durgs
  • DeliveryTime: 2-7days
  • PackAge: Disguised package
  • Port: HongKong
  • ProductionCapacity: 1000 Kilogram/Week
  • Purity: 99
  • Storage: Cool and dry
  • Transportation: by air
  • LimitNum: 10 Gram


1) our company is a professional raw powder factory in china for over 15 years, all powders are factory directly supplying.

2) our products have exported to germany, norway, poland, finland, spain, uk, france, russia, usa, australia, japan, korea and many other countries, over 100kgs each month.

3) professional team special for package and shipment and staring on tracking code 24hours for customs pass guaranteed. 100% pass to uk, norway, poland, spain, usa, canada, brazil; 98% pass to germany, russia, australia, new zealand.

4) most of powders are in stock, chargeable samples are available, could be shipped out within 24hours.

5) high quality, good price, fast and safety delivery. shipment by dhl, t1t, fedex, hkems, ems, etc


product description

new type fat loss durgs cetilistat with good results 282526-98-1

cetilistat info:

synonyms:cetilstat;2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one;2-(hexadecycloxy)-6-methyl-4h-3,1-benzoxazin-4-one;4h-3,1-benzoxazin-4-one,2-(hexadecyloxy)-6-methyl-;xinli orlistat
mf: c25h39no3
chemical properties:off-white cryst
usage:a novel pancreatic lipase inhibitor for the treatment of obesity in both diabetic and non-diabetic patients.

what is cetilistat

cetilistat is a drug designed to treat obesity. it acts in the same way as the older drug orlistat by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.

in human trials, cetilistat was shown to produce similar weight loss to orlistat, but also produced similar side effects such as oily, loose stools, fecal incontinence, frequent bowel movements, and flatulence. it is likely that the same precautions would apply in that absorption of fat-soluble vitamins and other fat-soluble nutrients may be inhibited, requiring vitamin supplements to be used to avoid deficiencies.

cetilistat coa:
test items specification test results
appearance white or almost white crystallime powder white powder
loss on drying ≤1.0 % 0.86%
melting point 72~76 ºc 73.5-75.2ºc
residue on ignition ≤ 0.5% 0.33%
related substances ≤ 1.0 % 0.44%
heavy metals (ppm) ≤ 20 ppm conformed
assay ≥ 99 % 99.65%

new type fat loss durgs cetilistat with good results 282526-98-1

uses for cetilistat:

cetislim (cetilistat) is a weight loss drug used in combination with a low calorie diet. it works by blocking a substantial amount of fat from being digested and absorbed into the body. this medicine is classified as a lipase inhibitor and it works directly on the digestive system where it blocks the action of a lipolytic enzyme called lipase. these lipases are what the body uses to digest the fat.

however, when this medicine is administered alongside a meal, it binds to the lipases, thereby inhibiting them from breaking down the fat. fats which are not hydrolyzed are instead excreted in the feces, resulting in increased fecal fat excretion and reduced fat absorption. when used together with a reduced calorie diet, it can help improve weight loss and make it easier for overweight patients to get back in shape, thereby boosting the chances of successful weight loss.


1. chronic sufferer malabsorption syndrome,cholestasis are prohibited.
2. organic obese patients(for example:hypothyroidism) disabled.
3. pregnant women are prohibited.
4. for orlistat, or any kind of ingredient in drug preparation allergy patients disabled.

therapeutic approaches to treatment of obesity

the growing prevalence of obesity has stimulated the search for drugs to treat this condition. various therapeutic strategies have been explored, including:

serotonin and noradrenaline reuptake inhibitors (anorectic agents)
lipase inhibitors
b 3-adrenoreceptor agonists
leptin agonists
melanocortin-3 agonists
endocannabinoid receptor antagonists
cetilistat is a lipase inhibitor, with a similar mode of action to roche's anti-obesity medication orlistat which received regulatory approval in 1997. these drugs act in the gastrointestinal tract to inhibit lipases, enzymes involved in the breakdown of dietary fats. by inhibiting the breakdown and subsequent absorption of fats from the gut, lipase inhibitors reduce fat intake and calories, thus aiding weight loss.

fat loss products

orlista cas:96829-58-2 cetilista cas:282526-98-1
rimonabant cas:168273-06-1 amp citrate n/a
1,3-dimethylpentylamine hcl/ dmaa cas:13803-74-2
1,3-dimethylbutylamine hcl / dmba cas: 71776-70-0 t4 levothyroxine sodium cas:55-03-8
lorcaserin hydrochloride cas:856681-05-5 t3 liothyronine sodium cas:55-06-1
l-carnitine cas:541-15-1 l-thyroxine cas:51-48-9

Send a message direct to supplier(s)

Enter email or Member ID
Tai'an Jia Ye Biological Technology Co.,Ltd

-Enter between 20 to 2000 letters.English only. Word count:0 letter(s).
-We suggest you include in your inquiry a brief introduction to your company as well as your product requirements